Showing results (191-200 of 247) with videos related to

Sort By:
Pageof 25
Clinical Pharmacology and Therapeutics|September 15, 2001
Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion techniqueO von Richter, B Greiner, M F Fromm, et al.
The American Journal of Pathology|November 14, 2000
The effect of rifampin treatment on intestinal expression of human MRP transportersM F Fromm, H M Kauffmann, P Fritz, et al.
The American Journal of Cardiology|February 1, 1985
Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmiasH J Duff, D M Roden, A Yacobi, et al.
Clinical Pharmacology and Therapeutics|May 27, 2008
Development of a large-scale de-identified DNA biobank to enable personalized medicineD M Roden, J M Pulley, M A Basford, et al.
The New England Journal of Medicine|April 17, 1980
Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristicsD M Roden, S B Reele, S B Higgins, et al.
Southern Medical Journal|September 1, 1981
Recurrent ventricular tachycardia in the absence of overt heart disease: clinical characteristics and response to drug therapyD M Roden, H J Duff, S B Reele, et al.
Clinical Pharmacology and Therapeutics|May 1, 1989
Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testingK T Murray, J T Barbey, H A Kopelman, et al.
The American Journal of Cardiology|September 1, 1980
Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamideD M Roden, S B Reele, S B Higgins, et al.
Clinical Pharmacology and Therapeutics|May 1, 1988
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmiasT Wang, L A Siddoway, K A Thompson, et al.
Journal of Cardiovascular Electrophysiology|September 1, 1995
A randomized, double-blind, placebo-controlled, dose-ranging study of dofetilide in patients with inducible sustained ventricular tachyarrhythmiasD S Echt, J T Lee, K T Murray, et al.
Pageof 25